Biography:
Dr. Yongqing Li, M.D., Ph.D., is an Associate Professor of Surgery at the University of Michigan renowned for his work in sepsis and trauma treatment. He earned his M.D. in China and a Ph.D. in Biochemistry and Molecular Biology from the University of Miami Medical School in the US. Following his postdoctoral training at UNC Chapel Hill and Harvard Medical School, he joined Massachusetts General Hospital in 2005 and was promoted to Assistant Professor at Harvard in 2011. One of his research interests is HDAC inhibition for sepsis treatment, in which he has made significant contributions with 23 published articles.
Title : HDAC6 inhibition and CitH3-mAb: Advancements in sepsis treatment
Title : Ongoing journey – targeting citrullinated histone H3 (CitH3) for early diagnosis and treatment of sepsis